Our products

Download the Summary of Product Characteristics (SPC) and Patient Information Leaflets (PILs) for our haemostasis products here:

 

NovoEight®- turoctocog alfa
(human coagulation factor VIII (rDNA))


PIP Code
NovoEight® 250 IU
402-7744
PIL
 
NovoEight®500 IU 402-7751
PIL

NovoEight®1000 IU 402-7769
PIL

NovoEight® 1500 IU 402-7777
PIL
 
NovoEight®2000 IU 402-7785
PIL
 
NovoEight®3000 IU 402-7793
PIL

   
Summary of Product Characteristics - Click here  
Guide to using NovoEight® - Click here to view video  
   
   

NovoSeven® - eptacog alfa (activated)

PIP Code

NovoSeven® 1mg

377-1672
PIL

NovoSeven® 2mg

377-1680
PIL

NovoSeven® 5mg

377-1698
PIL

NovoSeven® 8mg

377-1760
PIL


Summary of Product Characteristics - Click here

 

 

 

 

 

 This medicine is subject to additional safety monitoring.  This will allow quick identification of new safety information.  You can help by reporting any side effects you may get.  See mhra.gov.uk/yellowcard for how to report side effects.                      

                                                

 

 

 

 

 

 

This page is intended for UK healthcare professionals only

UK/WB/0416/0010(3)  October 2017